ABBVIE Share Price

ABBVIE Share Price

NYSE: ABBV | Mega Cap | Healthcare
$286.42
+$2.84 (1.00%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • Similar Stocks
  • FAQs

ABBVIE Stock Performance

Open
$286.74
Prev. Close
$283.57
Circuit Range
N/A
Day Range
$284.88 - $290.23
Year Range
$191.33 - $302.85
Volume
3,99,570
Average Traded
$288.01

ABBVIE Share Price Today

As of 21 November 2026, ABBVIE INC.'s share price is $286.42. The stock opened at $286.74, compared to its previous close of $283.57. During today's trading session, ABBVIE INC.'s share price traded between $284.88 and $290.23, with an average price of $287.56. Over the past 52 weeks, the stock has recorded a high of $302.85 and a low of $191.33. In terms of performance, ABBVIE INC.'s share price has risen by 31.53% over the last six months and is up 25.75% on a year-on-year basis.

ABBVIE Share Price Chart

Line chart of the ABBVIE price trend over the selected period. The price rose overall, ranging from 284.91 to 290.08, ending at 286.42.
$284.88$290.23
L
Show Current Price
H

ABBVIE Stock Fundamentals & Key Indicators

Market Cap
$506.67B
PE Ratio (TTM)
48.51
Dividend Yield
2.42%
EPS (TTM)
$5.85
Revenue (TTM)
$61.16B
Return On Equity (TTM)
-225.44%
Profit Margin
6.85%
Debt to Equity
-17.65
Quarterly Earnings Growth YoY
133.15%

ABBVIE Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$16.62$15.00$16.99$17.40
Net Profit$1.81$0.70$3.61$4.22
Net Profit Margin10.89%4.67%21.25%24.25%
Income ChangeN/A-61.33%415.71%16.90%

ABBVIE Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$58.05$54.32$56.33$61.16
Net Profit$11.84$4.82$4.24$4.19
Net Profit Margin20.40%8.87%7.53%6.85%
Income ChangeN/A-59.29%-12.03%-1.18%

ABBVIE Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets104.9109.58101.71110.34
Current Assets29.0625.5833.028.46
Total Assets133.96135.16134.71138.81
Non Current Liabilities93.993.0586.4791.98
Current Liabilities43.2938.7537.8429.54
Total Liabilities137.19131.8124.31121.52
Shareholders' Equity-3.233.3610.417.29

ABBVIE Cash Flow

Annually

All figures in USD Billion

Particulars2025202420232022
Operating19.018.822.824.9
Investing-6.6-20.8-2.0-0.6
Financing-12.7-5.2-17.2-24.8

Corporate Actions

Dividend
Ex-date: 15 Jan 2027

Dividend
Ex-date: 15 Oct 2026

Dividend
Ex-date: 15 Jul 2026

Dividend
Ex-date: 15 Apr 2026

Dividend
Ex-date: 16 Jan 2026

Dividend
Ex-date: 15 Oct 2025

Dividend
Ex-date: 15 Jul 2025

Dividend
Ex-date: 15 Apr 2025

Dividend
Ex-date: 15 Jan 2025

Dividend
Ex-date: 15 Oct 2024

Dividend
Ex-date: 15 Jul 2024

Dividend
Ex-date: 12 Apr 2024

About ABBVIE

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.

ABBVIE Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$292.88
$285.56
-2.94%
Oct 2026
$260.56
$294.21
+12.12%
Sep 2026
$260.84
$262.40
+1.65%
Aug 2026
$251.95
$258.14
+2.89%
Jul 2026
$250.81
$250.88
-0.17%
Jun 2026
$215.88
$251.31
+15.41%
May 2026
$209.44
$217.76
+3.02%
Apr 2026
$218.48
$211.38
-2.79%
Mar 2026
$234.18
$217.46
-6.36%
Feb 2026
$224.78
$232.22
+4.14%
Jan 2026
$228.21
$223.00
-2.40%
Dec 2025
$227.70
$228.48
+0.31%

ABBVIE Share Price FAQs